Table: quality_incentive_pool_qip_program_data_year_3

py	hospital	type	number	title	report_status	baseline_rate	baseline_rate_annotation_code	target_rate	numerator	numerator_annotation_code	denominator	denominator_annotation_code	achievement_rate	achievement_rate_annotation_code	achievement_value
'PY3'	'Alameda Health System'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0'	'0'	'0.4444'	'1198'	'0'	'2204'	'0'	'0.5436'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.7634'	'0'	'0.3869'	'1667'	'0'	'1906'	'0'	'0.8746'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.5882'	'0'	'0.2628'	'166'	'0'	'273'	'0'	'0.6081'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'320'	'0'	'517'	'0'	'0.619'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'363'	'0'	'653'	'0'	'0.5559'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'189'	'0'	'224'	'0'	'0.8438'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Reported'	'0'	'0'	'0.59'	'68'	'0'	'78'	'0'	'0.8718'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.8351'	'0'	'0.25'	'100'	'0'	'114'	'0'	'0.8772'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9549'	'0'	'0.5'	'204'	'0'	'208'	'0'	'0.9808'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.92'	'0'	'0.5'	'237'	'0'	'257'	'0'	'0.9222'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9339'	'0'	'0.5'	'171'	'0'	'188'	'0'	'0.9096'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9152'	'0'	'0.5'	'165'	'0'	'173'	'0'	'0.9538'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	'0'	'0'	'1.254'	''	'1'	'7.267'	'0'	''	'1'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.9932'	'0'	'0.25'	'542'	'0'	'560'	'0'	'0.9679'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'1'	'0'	'0.25'	'717'	'0'	'757'	'0'	'0.9472'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Reported'	'0.881'	'0'	'0.25'	'29'	'0'	'33'	'0'	'0.8788'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'0.8649'	'0'	'0.25'	'48'	'0'	'49'	'0'	'0.9796'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	'0'	'0'	'201'	'0'	'0'	'0'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Alameda Health System'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0527'	'0'	'0.1675'	''	'1'	'418'	'0'	''	'1'	'1'
'PY3'	'Alameda Health System'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Reported'	'0'	'0'	'0.0564'	''	'1'	'565'	'0'	''	'1'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5399'	'0'	'0.4444'	'665'	'0'	'1191'	'0'	'0.5584'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.5133'	'0'	'0.5085'	'672'	'0'	'1191'	'0'	'0.5642'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.618'	'0'	'0.562'	'932'	'0'	'1191'	'0'	'0.7825'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.1826'	'0'	'0.3869'	'386'	'0'	'991'	'0'	'0.3895'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.5417'	'0'	'0.2628'	'188'	'0'	'303'	'0'	'0.6205'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0.4438'	'0'	'0.28'	'143'	'0'	'340'	'0'	'0.4206'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0.5489'	'0'	'0.51'	'196'	'0'	'296'	'0'	'0.6622'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.6515'	'0'	'0.25'	'142'	'0'	'166'	'0'	'0.8554'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9157'	'0'	'0.5'	'309'	'0'	'335'	'0'	'0.9224'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.7109'	'0'	'0.5'	'190'	'0'	'280'	'0'	'0.6786'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.7619'	'0'	'0.5'	'133'	'0'	'150'	'0'	'0.8867'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.7985'	'0'	'0.5'	'351'	'0'	'386'	'0'	'0.9093'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.6193'	'0'	'0.5'	'174'	'0'	'248'	'0'	'0.7016'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	'0.8293'	'0'	'1.254'	''	'1'	'6.098'	'0'	''	'1'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.2708'	'0'	'0.25'	'64'	'0'	'103'	'0'	'0.6214'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.8571'	'0'	'0.25'	'123'	'0'	'423'	'0'	'0.2908'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.8438'	'0'	'0.25'	'70'	'0'	'83'	'0'	'0.8434'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	''	'4'	'N/A'	'54'	'0'	'59'	'0'	'0.9153'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	'25'	'0'	'249'	'0'	'0.1004'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0704'	'0'	'0.1675'	'78'	'0'	'472'	'0'	'0.1653'	'0'	'1'
'PY3'	'Arrowhead Regional Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.583'	'0'	'0.4444'	'2456'	'0'	'4164'	'0'	'0.5898'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.6198'	'0'	'0.5085'	'2676'	'0'	'4164'	'0'	'0.6427'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7709'	'0'	'0.562'	'3222'	'0'	'4164'	'0'	'0.7738'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Reported'	'0.5795'	'0'	'0.5685'	'715'	'0'	'993'	'0'	'0.72'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.9959'	'0'	'0.3869'	'2167'	'0'	'2185'	'0'	'0.9918'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC7'	'? 12-24 Months'	'Reported'	'0.9541'	'0'	'0.9364'	'1013'	'0'	'1056'	'0'	'0.9593'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC7'	'? 25 Months-6 Years'	'Reported'	'0.8636'	'0'	'0.8439'	'5074'	'0'	'5732'	'0'	'0.8852'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC7'	'? 7-11 Years'	'Reported'	'0.8895'	'0'	'0.8773'	'4385'	'0'	'4891'	'0'	'0.8965'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC7'	'? 12-19 Years'	'Reported'	'0.8727'	'0'	'0.8581'	'6155'	'0'	'6965'	'0'	'0.8837'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.4994'	'0'	'0.2628'	'461'	'0'	'848'	'0'	'0.5436'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'1263'	'0'	'2569'	'0'	'0.4916'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.8237'	'0'	'0.25'	'417'	'0'	'506'	'0'	'0.8241'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9253'	'0'	'0.5'	'1707'	'0'	'1866'	'0'	'0.9148'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.7884'	'0'	'0.5'	'808'	'0'	'1042'	'0'	'0.7754'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.9164'	'0'	'0.5'	'419'	'0'	'459'	'0'	'0.9129'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.8259'	'0'	'0.5'	'392'	'0'	'469'	'0'	'0.8358'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9755'	'0'	'0.5'	'480'	'0'	'501'	'0'	'0.9581'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.9736'	'0'	'0.25'	'474'	'0'	'500'	'0'	'0.948'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9676'	'0'	'0.25'	'587'	'0'	'606'	'0'	'0.9686'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.8707'	'0'	'0.25'	'122'	'0'	'131'	'0'	'0.9313'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	''	'1'	'950'	'0'	''	'1'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0791'	'0'	'0.1675'	'115'	'0'	'1788'	'0'	'0.0643'	'0'	'1'
'PY3'	'Contra Costa Regional Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Reported'	'0'	'0'	'0.0564'	'61'	'0'	'1483'	'0'	'0.0411'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5676'	'0'	'0.4444'	'1103'	'0'	'1955'	'0'	'0.5642'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7149'	'0'	'0.562'	'1326'	'0'	'1955'	'0'	'0.6783'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Reported'	'0.7419'	'0'	'0.5685'	'29'	'0'	'43'	'0'	'0.6744'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.8358'	'0'	'0.3869'	'866'	'0'	'1001'	'0'	'0.8651'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.3617'	'0'	'0.2628'	'130'	'0'	'298'	'0'	'0.4362'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'68'	'0'	'102'	'0'	'0.6667'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.9573'	'0'	'0.25'	'90'	'0'	'97'	'0'	'0.9278'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9562'	'0'	'0.5'	'290'	'0'	'298'	'0'	'0.9732'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.9368'	'0'	'0.5'	'174'	'0'	'187'	'0'	'0.9305'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.9624'	'0'	'0.5'	'118'	'0'	'129'	'0'	'0.9147'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.978'	'0'	'0.5'	'81'	'0'	'82'	'0'	'0.9878'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.967'	'0'	'0.5'	'82'	'0'	'85'	'0'	'0.9647'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'1'	'0'	'0.25'	'868'	'0'	'868'	'0'	'1'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.999'	'0'	'0.25'	'811'	'0'	'811'	'0'	'1'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.9126'	'0'	'0.25'	'259'	'0'	'261'	'0'	'0.9923'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'1'	'0'	'0.25'	'35'	'0'	'35'	'0'	'1'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	'0'	'0'	'0.75'	''	'1'	'138'	'0'	''	'1'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Reported'	'0.9116'	'0'	'0.5'	'74'	'0'	'76'	'0'	'0.9737'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Kern Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0327'	'0'	'0.1675'	'12'	'0'	'716'	'0'	'0.0168'	'0'	'1'
'PY3'	'Kern Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Reported'	'0'	'0'	'0.0564'	'0'	'0'	'543'	'0'	'0'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5318'	'0'	'0.4444'	'7286'	'0'	'13571'	'0'	'0.5369'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.7129'	'0'	'0.5085'	'9650'	'0'	'13571'	'0'	'0.7111'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7011'	'0'	'0.562'	'9646'	'0'	'13571'	'0'	'0.7108'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Reported'	'0.7072'	'0'	'0.5685'	'1045'	'0'	'1132'	'0'	'0.9231'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.646'	'0'	'0.3869'	'5333'	'0'	'7679'	'0'	'0.6945'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.6331'	'0'	'0.2628'	'206'	'0'	'323'	'0'	'0.6378'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0.5356'	'0'	'0.28'	'147'	'0'	'323'	'0'	'0.4551'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0.8074'	'0'	'0.6636'	'2261'	'0'	'2788'	'0'	'0.811'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.863'	'0'	'0.25'	'739'	'0'	'849'	'0'	'0.8704'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9213'	'0'	'0.5'	'2820'	'0'	'2926'	'0'	'0.9638'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.8975'	'0'	'0.5'	'1485'	'0'	'1651'	'0'	'0.8995'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.8716'	'0'	'0.5'	'940'	'0'	'1054'	'0'	'0.8918'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.8557'	'0'	'0.5'	'580'	'0'	'691'	'0'	'0.8394'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.8913'	'0'	'0.5'	'631'	'0'	'701'	'0'	'0.9001'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.9655'	'0'	'0.25'	'370'	'0'	'377'	'0'	'0.9814'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9735'	'0'	'0.25'	'364'	'0'	'377'	'0'	'0.9655'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Reported'	'0.954'	'0'	'0.25'	'72'	'0'	'73'	'0'	'0.9863'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'1'	'0'	'0.25'	'177'	'0'	'177'	'0'	'1'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	'0'	'0'	'324'	'0'	'0'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0857'	'0'	'0.1675'	'226'	'0'	'2859'	'0'	'0.079'	'0'	'1'
'PY3'	'Los Angeles County Health System'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5385'	'0'	'0.4444'	'951'	'0'	'1897'	'0'	'0.5013'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.5687'	'0'	'0.5085'	'1063'	'0'	'1897'	'0'	'0.5604'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7425'	'0'	'0.562'	'1303'	'0'	'1897'	'0'	'0.6869'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.6087'	'0'	'0.3869'	'427'	'0'	'737'	'0'	'0.5794'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.7801'	'0'	'0.2628'	'778'	'0'	'963'	'0'	'0.8079'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'678'	'0'	'1091'	'0'	'0.6214'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'171'	'0'	'257'	'0'	'0.6654'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.8832'	'0'	'0.25'	'109'	'0'	'126'	'0'	'0.8651'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.8159'	'0'	'0.5'	'242'	'0'	'292'	'0'	'0.8288'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.8352'	'0'	'0.5'	'138'	'0'	'165'	'0'	'0.8364'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.8857'	'0'	'0.5'	'59'	'0'	'71'	'0'	'0.831'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9024'	'0'	'0.5'	'33'	'0'	'37'	'0'	'0.8919'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'1'	'0'	'0.5'	'36'	'0'	'37'	'0'	'0.973'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	'0.5413'	'0'	'1.254'	''	'1'	'5.577'	'0'	''	'1'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.6332'	'0'	'0.25'	'344'	'0'	'531'	'0'	'0.6478'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9351'	'0'	'0.25'	'451'	'0'	'478'	'0'	'0.9435'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.8832'	'0'	'0.25'	'150'	'0'	'184'	'0'	'0.8152'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	'0'	'0'	'0.75'	''	'1'	'77'	'0'	''	'1'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Natividad Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0759'	'0'	'0.1675'	'24'	'0'	'352'	'0'	'0.0682'	'0'	'1'
'PY3'	'Natividad Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Reported'	'0'	'0'	'0.0564'	''	'1'	'269'	'0'	''	'1'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5634'	'0'	'0.4444'	'1911'	'0'	'3542'	'0'	'0.5395'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7469'	'0'	'0.562'	'2593'	'0'	'3542'	'0'	'0.7321'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.9801'	'0'	'0.3869'	'1495'	'0'	'1527'	'0'	'0.979'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.3775'	'0'	'0.2628'	'121'	'0'	'265'	'0'	'0.4566'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'73'	'0'	'240'	'0'	'0.3042'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Reported'	'0'	'0'	'0.1855'	'4014'	'0'	'13993'	'0'	'0.2869'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'1562'	'0'	'2414'	'0'	'0.6471'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'504'	'0'	'640'	'0'	'0.7875'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.8618'	'0'	'0.25'	'127'	'0'	'142'	'0'	'0.8944'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.8804'	'0'	'0.5'	'291'	'0'	'328'	'0'	'0.8872'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.8889'	'0'	'0.5'	'155'	'0'	'179'	'0'	'0.8659'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	''	'1'	'1.254'	''	'1'	'10.712'	'0'	''	'1'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.8171'	'0'	'0.25'	'177'	'0'	'209'	'0'	'0.8469'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9019'	'0'	'0.25'	'415'	'0'	'419'	'0'	'0.9905'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Riverside University Health System'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'0.8939'	'0'	'0.25'	'55'	'0'	'55'	'0'	'1'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	'0'	'0'	'0.75'	''	'1'	'149'	'0'	''	'1'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Reported'	'0.8247'	'0'	'0.5'	'182'	'0'	'194'	'0'	'0.9381'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Reported'	''	'1'	'0.5'	''	'1'	'63'	'0'	''	'1'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0'	'0'	'0.1675'	'68'	'0'	'2433'	'0'	'0.0279'	'0'	'1'
'PY3'	'Riverside University Health System'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Reported'	'0'	'0'	'0.0564'	'32'	'0'	'1422'	'0'	'0.0225'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.618'	'0'	'0.4444'	'1294'	'0'	'2358'	'0'	'0.5488'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.6803'	'0'	'0.5085'	'1425'	'0'	'2358'	'0'	'0.6043'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7676'	'0'	'0.562'	'1703'	'0'	'2358'	'0'	'0.7222'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.5842'	'0'	'0.3869'	'1569'	'0'	'2145'	'0'	'0.7315'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC7'	'? 12-24 Months'	'Reported'	'0'	'0'	'0.9364'	'338'	'0'	'353'	'0'	'0.9575'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC7'	'? 25 Months-6 Years'	'Reported'	'0'	'0'	'0.8439'	'1867'	'0'	'2161'	'0'	'0.864'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC7'	'? 7-11 Years'	'Reported'	'0'	'0'	'0.8773'	'1537'	'0'	'1733'	'0'	'0.8869'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC7'	'? 12-19 Years'	'Reported'	'0'	'0'	'0.8581'	'1923'	'0'	'2187'	'0'	'0.8793'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.7519'	'0'	'0.2628'	'209'	'0'	'272'	'0'	'0.7684'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'290'	'0'	'475'	'0'	'0.6105'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'546'	'0'	'702'	'0'	'0.7778'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'1316'	'0'	'1636'	'0'	'0.8044'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.8'	'0'	'0.25'	'231'	'0'	'289'	'0'	'0.7993'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9407'	'0'	'0.5'	'703'	'0'	'760'	'0'	'0.925'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.8818'	'0'	'0.5'	'315'	'0'	'365'	'0'	'0.863'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.9638'	'0'	'0.5'	'158'	'0'	'162'	'0'	'0.9753'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.8467'	'0'	'0.5'	'385'	'0'	'457'	'0'	'0.8425'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9254'	'0'	'0.5'	'396'	'0'	'428'	'0'	'0.9252'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.9585'	'0'	'0.25'	'325'	'0'	'355'	'0'	'0.9155'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9672'	'0'	'0.25'	'712'	'0'	'753'	'0'	'0.9456'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.57'	'0'	'0.25'	'300'	'0'	'409'	'0'	'0.7335'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Reported'	'1'	'0'	'0.25'	'44'	'0'	'44'	'0'	'1'	'0'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	''	'1'	'173'	'0'	''	'1'	'1'
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Francisco General Hospital'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5277'	'0'	'0.4444'	'960'	'0'	'1916'	'0'	'0.501'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.5012'	'0'	'0.5085'	'216'	'0'	'411'	'0'	'0.5255'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.6807'	'0'	'0.562'	'1280'	'0'	'1916'	'0'	'0.6681'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Reported'	'0.7273'	'0'	'0.5685'	'37'	'0'	'59'	'0'	'0.6271'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.9496'	'0'	'0.3869'	'121'	'0'	'249'	'0'	'0.4859'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.5779'	'0'	'0.2628'	'83'	'0'	'169'	'0'	'0.4911'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'180'	'0'	'409'	'0'	'0.4401'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'31'	'0'	'43'	'0'	'0.7209'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Reported'	'0'	'0'	'0.59'	'260'	'0'	'489'	'0'	'0.5317'	'0'	'0'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.7823'	'0'	'0.25'	'110'	'0'	'157'	'0'	'0.7006'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.8753'	'0'	'0.5'	'273'	'0'	'353'	'0'	'0.7734'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.8762'	'0'	'0.5'	'170'	'0'	'212'	'0'	'0.8019'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.8931'	'0'	'0.5'	'125'	'0'	'138'	'0'	'0.9058'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9487'	'0'	'0.5'	'116'	'0'	'135'	'0'	'0.8593'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9417'	'0'	'0.5'	'127'	'0'	'134'	'0'	'0.9478'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	''	'1'	'1.254'	'11'	'0'	'10.958'	'0'	'1.0038'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.7492'	'0'	'0.25'	'291'	'0'	'303'	'0'	'0.9604'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.8237'	'0'	'0.25'	'334'	'0'	'398'	'0'	'0.8392'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.9091'	'0'	'0.25'	'82'	'0'	'88'	'0'	'0.9318'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'0.9722'	'0'	'0.25'	'96'	'0'	'97'	'0'	'0.9897'	'0'	'1'
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Joaquin General Hospital'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5913'	'0'	'0.4444'	'2668'	'0'	'4783'	'0'	'0.5578'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.6843'	'0'	'0.5085'	'2944'	'0'	'4783'	'0'	'0.6155'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.6994'	'0'	'0.562'	'3151'	'0'	'4783'	'0'	'0.6588'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.5254'	'0'	'0.3869'	'2002'	'0'	'3961'	'0'	'0.5054'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.4867'	'0'	'0.2628'	'600'	'0'	'1210'	'0'	'0.4959'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'1110'	'0'	'1706'	'0'	'0.6506'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'893'	'0'	'1451'	'0'	'0.6154'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'474'	'0'	'556'	'0'	'0.8525'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.7022'	'0'	'0.25'	'298'	'0'	'423'	'0'	'0.7045'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.8636'	'0'	'0.5'	'965'	'0'	'1047'	'0'	'0.9217'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.7682'	'0'	'0.5'	'436'	'0'	'561'	'0'	'0.7772'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.726'	'0'	'0.5'	'336'	'0'	'369'	'0'	'0.9106'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0'	'0'	'N/A'	'408'	'0'	'459'	'0'	'0.8889'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.7598'	'0'	'0.5'	'426'	'0'	'459'	'0'	'0.9281'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.7468'	'0'	'0.25'	'1330'	'0'	'1489'	'0'	'0.8932'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9517'	'0'	'0.25'	'1195'	'0'	'1257'	'0'	'0.9507'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.3202'	'0'	'0.25'	'482'	'0'	'720'	'0'	'0.6694'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Reported'	'0.7073'	'0'	'0.25'	'33'	'0'	'49'	'0'	'0.6735'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'0.9556'	'0'	'0.25'	'90'	'0'	'115'	'0'	'0.7826'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0762'	'0'	'0.1675'	'136'	'0'	'1215'	'0'	'0.1119'	'0'	'1'
'PY3'	'Santa Clara Valley Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.6213'	'0'	'0.4444'	'729'	'0'	'1257'	'0'	'0.58'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.9878'	'0'	'0.5085'	'1239'	'0'	'1257'	'0'	'0.9857'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7597'	'0'	'0.562'	'943'	'0'	'1257'	'0'	'0.7502'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Reported'	'0.6218'	'0'	'0.5685'	'97'	'0'	'102'	'0'	'0.951'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.5681'	'0'	'0.3869'	'196'	'0'	'387'	'0'	'0.5065'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC7'	'? 12-24 Months'	'Reported'	'1'	'0'	'0.9364'	'255'	'0'	'256'	'0'	'0.9961'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC7'	'? 25 Months-6 Years'	'Reported'	'0.9502'	'0'	'0.8439'	'2104'	'0'	'2150'	'0'	'0.9786'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC7'	'? 7-11 Years'	'Reported'	'0.9652'	'0'	'0.8773'	'1866'	'0'	'1879'	'0'	'0.9931'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC7'	'? 12-19 Years'	'Reported'	'0.9582'	'0'	'0.8581'	'2668'	'0'	'2685'	'0'	'0.9937'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.6877'	'0'	'0.2628'	'196'	'0'	'286'	'0'	'0.6853'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0.7335'	'0'	'0.28'	'200'	'0'	'298'	'0'	'0.6711'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.8078'	'0'	'0.25'	'113'	'0'	'140'	'0'	'0.8071'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9163'	'0'	'0.5'	'339'	'0'	'369'	'0'	'0.9187'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.9006'	'0'	'0.5'	'160'	'0'	'192'	'0'	'0.8333'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.9096'	'0'	'0.5'	'100'	'0'	'109'	'0'	'0.9174'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9077'	'0'	'0.5'	'38'	'0'	'41'	'0'	'0.9268'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9625'	'0'	'0.5'	'48'	'0'	'49'	'0'	'0.9796'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.969'	'0'	'0.25'	'314'	'0'	'459'	'0'	'0.6841'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9924'	'0'	'0.25'	'449'	'0'	'456'	'0'	'0.9846'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.7239'	'0'	'0.25'	'68'	'0'	'86'	'0'	'0.7907'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	''	'1'	'110'	'0'	''	'1'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Reported'	'0.8191'	'0'	'0.5'	'124'	'0'	'147'	'0'	'0.8435'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0.0743'	'0'	'0.1675'	'67'	'0'	'1073'	'0'	'0.0624'	'0'	'1'
'PY3'	'San Mateo Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0'	'0'	'0.4444'	'60'	'0'	'106'	'0'	'0.566'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0'	'0'	'0.5085'	'81'	'0'	'106'	'0'	'0.7642'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0'	'0'	'0.562'	'89'	'0'	'106'	'0'	'0.8396'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'1'	'0'	'0.3869'	'167'	'0'	'234'	'0'	'0.7137'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Reported'	'0'	'0'	'0.1855'	'100'	'0'	'242'	'0'	'0.4132'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'21'	'0'	'38'	'0'	'0.5526'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.75'	'0'	'0.5'	'46'	'0'	'59'	'0'	'0.7797'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	''	'4'	'0.5'	'36'	'0'	'37'	'0'	'0.973'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	''	'4'	'0.5'	'58'	'0'	'68'	'0'	'0.8529'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	''	'4'	'0.5'	'83'	'0'	'84'	'0'	'0.9881'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	'1.0107'	'0'	'1.254'	'36'	'0'	'38.106'	'0'	'0.9447'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.8268'	'0'	'0.25'	'1406'	'0'	'1768'	'0'	'0.7952'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9555'	'0'	'0.25'	'2005'	'0'	'2196'	'0'	'0.913'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.8738'	'0'	'0.25'	'304'	'0'	'323'	'0'	'0.9412'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Reported'	'0.9032'	'0'	'0.25'	'35'	'0'	'38'	'0'	'0.9211'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'0.9538'	'0'	'0.25'	'76'	'0'	'81'	'0'	'0.9383'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'4'	'0.75'	'0'	'0'	'73'	'0'	'0'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Reported'	'0.8014'	'0'	'0.5'	'271'	'0'	'278'	'0'	'0.9748'	'0'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Reported'	''	'1'	'0.5'	''	'1'	'132'	'0'	''	'1'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	'0'	'0'	'0.1675'	''	'1'	'84'	'0'	''	'1'	'1'
'PY3'	'UC Davis Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.45'	'0'	'0.4444'	'544'	'0'	'1065'	'0'	'0.5108'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.6704'	'0'	'0.562'	'764'	'0'	'1065'	'0'	'0.7174'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.9905'	'0'	'0.3869'	'504'	'0'	'507'	'0'	'0.9941'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC7'	'? 12-24 Months'	'Reported'	'0.9929'	'0'	'0.9364'	'282'	'0'	'290'	'0'	'0.9724'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC7'	'? 25 Months-6 Years'	'Reported'	'0.8747'	'0'	'0.8439'	'1189'	'0'	'1344'	'0'	'0.8847'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC7'	'? 7-11 Years'	'Reported'	'0.8714'	'0'	'0.8773'	'736'	'0'	'821'	'0'	'0.8965'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC7'	'? 12-19 Years'	'Reported'	'0.8512'	'0'	'0.8581'	'1285'	'0'	'1451'	'0'	'0.8856'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.4463'	'0'	'0.2628'	'70'	'0'	'145'	'0'	'0.4828'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0.4778'	'0'	'0.28'	'175'	'0'	'306'	'0'	'0.5719'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Reported'	'0.2129'	'0'	'0.1855'	'685'	'0'	'3054'	'0'	'0.2243'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0.5981'	'0'	'0.51'	'522'	'0'	'844'	'0'	'0.6185'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.8113'	'0'	'0.25'	'102'	'0'	'117'	'0'	'0.8718'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.8672'	'0'	'0.5'	'221'	'0'	'272'	'0'	'0.8125'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.8644'	'0'	'0.5'	'176'	'0'	'194'	'0'	'0.9072'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.912'	'0'	'0.5'	'124'	'0'	'134'	'0'	'0.9254'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.8874'	'0'	'0.5'	'151'	'0'	'165'	'0'	'0.9152'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9726'	'0'	'0.5'	'161'	'0'	'162'	'0'	'0.9938'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	'0.8606'	'0'	'1.254'	'30'	'0'	'34.858'	'0'	'0.8606'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.8004'	'0'	'0.25'	'371'	'0'	'531'	'0'	'0.6987'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Reported'	'0.8333'	'0'	'0.25'	'36'	'0'	'48'	'0'	'0.75'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	'17'	'0'	'153'	'0'	'0.1111'	'0'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Reported'	''	'1'	'0.5'	''	'1'	'90'	'0'	''	'1'	'1'
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Irvine Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Reported'	'0.0444'	'0'	'0.0564'	''	'1'	'249'	'0'	''	'1'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5571'	'0'	'0.4444'	'26'	'0'	'51'	'0'	'0.5098'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.3857'	'0'	'0.5085'	'26'	'0'	'51'	'0'	'0.5098'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7714'	'0'	'0.562'	'40'	'0'	'51'	'0'	'0.7843'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Reported'	''	'1'	'0.5685'	'65'	'0'	'65'	'0'	'1'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'1'	'0'	'0.3869'	'47'	'0'	'47'	'0'	'1'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC7'	'? 12-24 Months'	'Reported'	'0.8806'	'0'	'0.9364'	'144'	'0'	'146'	'0'	'0.9863'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC7'	'? 25 Months-6 Years'	'Reported'	'0.7233'	'0'	'0.8439'	'884'	'0'	'1010'	'0'	'0.8752'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC7'	'? 7-11 Years'	'Reported'	'0.8409'	'0'	'0.8773'	'745'	'0'	'830'	'0'	'0.8976'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC7'	'? 12-19 Years'	'Reported'	'0.857'	'0'	'0.8581'	'1078'	'0'	'1181'	'0'	'0.9128'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.4742'	'0'	'0.2628'	'66'	'0'	'149'	'0'	'0.443'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'71'	'0'	'173'	'0'	'0.4104'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Reported'	'0'	'0'	'0.1855'	'168'	'0'	'510'	'0'	'0.3294'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'79'	'0'	'137'	'0'	'0.5766'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'40'	'0'	'59'	'0'	'0.678'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Reported'	'0'	'0'	'0.59'	'39'	'0'	'65'	'0'	'0.6'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	'0.7787'	'0'	'1.254'	'20'	'0'	'30.955'	'0'	'0.6461'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.8556'	'0'	'0.25'	'639'	'0'	'743'	'0'	'0.86'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9663'	'0'	'0.25'	'819'	'0'	'888'	'0'	'0.9223'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.8039'	'0'	'0.25'	'1000'	'0'	'1365'	'0'	'0.7326'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'1'	'0'	'0.25'	'43'	'0'	'43'	'0'	'1'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Reported'	'0.9825'	'0'	'0.5'	'509'	'0'	'531'	'0'	'0.9586'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Reported'	'0'	'0'	'0.5'	'0'	'0'	'78'	'0'	'0'	'0'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-RU5'	'? RATE #2'	'Reported'	''	'1'	'0.1675'	''	'1'	'37'	'0'	''	'1'	'1'
'PY3'	'UC Los Angeles Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.6508'	'0'	'0.4444'	'228'	'0'	'359'	'0'	'0.6351'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.6533'	'0'	'0.5085'	'186'	'0'	'359'	'0'	'0.5181'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7462'	'0'	'0.562'	'250'	'0'	'359'	'0'	'0.6964'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Reported'	'0.6102'	'0'	'0.5685'	'52'	'0'	'83'	'0'	'0.6265'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.8745'	'0'	'0.3869'	'202'	'0'	'248'	'0'	'0.8145'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Reported'	'0'	'0'	'0.1855'	'223'	'0'	'701'	'0'	'0.3181'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'37'	'0'	'60'	'0'	'0.6167'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'644'	'0'	'803'	'0'	'0.802'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.9307'	'0'	'0.25'	'75'	'0'	'84'	'0'	'0.8929'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9251'	'0'	'0.5'	'178'	'0'	'198'	'0'	'0.899'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.871'	'0'	'0.5'	'91'	'0'	'98'	'0'	'0.9286'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.8989'	'0'	'0.5'	'55'	'0'	'61'	'0'	'0.9016'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9206'	'0'	'0.5'	'58'	'0'	'61'	'0'	'0.9508'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9344'	'0'	'0.5'	'60'	'0'	'61'	'0'	'0.9836'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Reported'	'0.621'	'0'	'1.254'	'28'	'0'	'44.11'	'0'	'0.6348'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.752'	'0'	'0.25'	'1026'	'0'	'1233'	'0'	'0.8321'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.7488'	'0'	'0.25'	'1103'	'0'	'1306'	'0'	'0.8446'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.5467'	'0'	'0.25'	'1093'	'0'	'1384'	'0'	'0.7897'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'1'	'0'	'0.25'	'48'	'0'	'49'	'0'	'0.9796'	'0'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Reported'	''	'1'	'0.75'	''	'1'	'178'	'0'	''	'1'	'1'
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Diego Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.5826'	'0'	'0.4444'	'308'	'0'	'502'	'0'	'0.6135'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.6607'	'0'	'0.5085'	'313'	'0'	'502'	'0'	'0.6235'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7297'	'0'	'0.562'	'357'	'0'	'502'	'0'	'0.7112'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.9908'	'0'	'0.3869'	'446'	'0'	'454'	'0'	'0.9824'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC7'	'? 12-24 Months'	'Reported'	'0'	'0'	'0.9364'	'207'	'0'	'215'	'0'	'0.9628'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC7'	'? 25 Months-6 Years'	'Reported'	'0'	'0'	'0.8439'	'1105'	'0'	'1257'	'0'	'0.8791'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC7'	'? 7-11 Years'	'Reported'	'0'	'0'	'0.8773'	'902'	'0'	'988'	'0'	'0.913'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC7'	'? 12-19 Years'	'Reported'	'0'	'0'	'0.8581'	'1270'	'0'	'1405'	'0'	'0.9039'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0'	'0'	'0.2628'	'73'	'0'	'170'	'0'	'0.4294'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'170'	'0'	'272'	'0'	'0.625'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Reported'	'0'	'0'	'0.1855'	'820'	'0'	'2401'	'0'	'0.3415'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'165'	'0'	'180'	'0'	'0.9167'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Reported'	'0'	'0'	'0.59'	'101'	'0'	'135'	'0'	'0.7481'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.9701'	'0'	'0.25'	'42'	'0'	'42'	'0'	'1'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.9873'	'0'	'0.5'	'120'	'0'	'122'	'0'	'0.9836'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.9604'	'0'	'0.5'	'57'	'0'	'59'	'0'	'0.9661'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'1'	'0'	'0.5'	'53'	'0'	'53'	'0'	'1'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9412'	'0'	'0.5'	'64'	'0'	'68'	'0'	'0.9412'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'1'	'0'	'0.5'	'63'	'0'	'64'	'0'	'0.9844'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.9178'	'0'	'0.25'	'2579'	'0'	'3112'	'0'	'0.8287'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9844'	'0'	'0.25'	'3639'	'0'	'3697'	'0'	'0.9843'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.4336'	'0'	'0.25'	'1192'	'0'	'1658'	'0'	'0.7189'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Reported'	'0.9688'	'0'	'0.25'	'29'	'0'	'30'	'0'	'0.9667'	'0'	'1'
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'UC San Francisco Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC1'	'Comprehensive Diabetes Care: A1C Control (<8%%) (CDC-H8)'	'Reported'	'0.6325'	'0'	'0.4444'	'1633'	'0'	'2633'	'0'	'0.6202'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC2'	'Comprehensive Diabetes Care: Eye Exam (CDC-E)'	'Reported'	'0.5394'	'0'	'0.5085'	'1613'	'0'	'2633'	'0'	'0.6126'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC3'	'Comprehensive Diabetes Care: Blood Pressure Control (CDC-BP)'	'Reported'	'0.7585'	'0'	'0.562'	'1978'	'0'	'2633'	'0'	'0.7512'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC4'	'Asthma Medication Ratio (AMR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC5'	'Medication Reconciliation Post Discharge (MRP)'	'Reported'	'0.5905'	'0'	'0.3869'	'952'	'0'	'1576'	'0'	'0.6041'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC7'	'Children and Adolescent Access to PCP (CAP)'	'Reported'	''	'3'	'N/A'	''	'3'	''	'3'	''	'3'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC7'	'? 12-24 Months'	'Reported'	'0.9554'	'0'	'0.9364'	'1376'	'0'	'1436'	'0'	'0.9582'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC7'	'? 25 Months-6 Years'	'Reported'	'0.8761'	'0'	'0.8439'	'6911'	'0'	'7736'	'0'	'0.8934'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC7'	'? 7-11 Years'	'Reported'	'0.9021'	'0'	'0.8773'	'7266'	'0'	'7923'	'0'	'0.9171'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC7'	'? 12-19 Years'	'Reported'	'0.8726'	'0'	'0.8581'	'9936'	'0'	'11223'	'0'	'0.8853'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC9'	'Immunization for Adolescents (IMA) Combination 2'	'Reported'	'0.387'	'0'	'0.2628'	'537'	'0'	'1461'	'0'	'0.3676'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC10'	'Childhood Immunization Status (CIS) Combination 10'	'Reported'	'0'	'0'	'0.28'	'600'	'0'	'1579'	'0'	'0.38'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC11'	'Contraceptive Care - All Women (CCW) Most and Moderately Effective Methods, Ages 15-44'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC12'	'Chlamydia Screening in Women (CHL), Ages 16-24'	'Reported'	'0'	'0'	'0.51'	'1172'	'0'	'2247'	'0'	'0.5216'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC13'	'HIV Viral Load Suppression (HVL-AD)'	'Reported'	'0'	'0'	'0.6636'	'150'	'0'	'201'	'0'	'0.7463'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-PC14'	'Well-Child Visits in the First 15 Months of Life (W15-CH), Six or More well-child visits'	'Reported'	'0'	'0'	'0.59'	'298'	'0'	'393'	'0'	'0.7583'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-SC1'	'Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy'	'Reported'	'0.7984'	'0'	'0.25'	'99'	'0'	'141'	'0'	'0.7021'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-SC2'	'Coronary Artery Disease (CAD): Antiplatelet Therapy'	'Reported'	'0.8929'	'0'	'0.5'	'384'	'0'	'440'	'0'	'0.8727'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-SC3'	'Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%%)'	'Reported'	'0.8554'	'0'	'0.5'	'200'	'0'	'234'	'0'	'0.8547'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-SC4'	'Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%%)'	'Reported'	'0.9104'	'0'	'0.5'	'75'	'0'	'84'	'0'	'0.8929'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-SC5'	'Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin-Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.8647'	'0'	'0.5'	'116'	'0'	'136'	'0'	'0.8529'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-SC6'	'Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction'	'Reported'	'0.9451'	'0'	'0.5'	'78'	'0'	'88'	'0'	'0.8864'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-IP1'	'Surgical Site Infection (SSI) (Reported as SIR)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-IP2'	'Perioperative Care: Selection of Prophylactic Antibiotic - 1st OR 2nd Generation Cephalosporin'	'Reported'	'0.8368'	'0'	'0.25'	'833'	'0'	'962'	'0'	'0.8659'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-IP3'	'Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis'	'Reported'	'0.9519'	'0'	'0.25'	'1047'	'0'	'1070'	'0'	'0.9785'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-IP4'	'Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections'	'Reported'	'0.8177'	'0'	'0.25'	'132'	'0'	'163'	'0'	'0.8098'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-IP5'	'Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-IP6'	'Stroke: Discharged on Antithrombotic Therapy (TJC STK-2)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-RU1'	'Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients (QPP)'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-RU2'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients 18 Years and Older'	'Reported'	'0.7388'	'0'	'0.5'	'150'	'0'	'197'	'0'	'0.7614'	'0'	'1'
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-RU3'	'Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 years old'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-RU5'	'Concurrent Use of Opioids and Benzodiazepines'	'Not Reported'	''	''	''	''	''	''	''	''	''	''
'PY3'	'Ventura County Medical Center'	'DPH'	'Q-RU6'	'Use of Opioids at high Dosage in Persons Without Cancer'	'Not Reported'	''	''	''	''	''	''	''	''	''	''